Adapting model-based deep learning to multiple acquisition conditions: Ada-MoDL.

PURPOSE: The aim of this work is to introduce a single model-based deep network that can provide high-quality reconstructions from undersampled parallel MRI data acquired with multiple sequences, acquisition settings, and field strengths. METHODS: A single unrolled architecture, which offers good reconstructions for multiple acquisition settings, is introduced. The proposed scheme adapts the model to each setting by scaling the convolutional neural network (CNN) features and the regularization parameter with appropriate weights. The scaling weights and regularization parameter are derived using a multilayer perceptron model from conditional vectors, which represents the specific acquisition setting. The perceptron parameters and the CNN weights are jointly trained using data from multiple acquisition settings, including differences in field strengths, acceleration, and contrasts. The conditional network is validated using datasets acquired with different acquisition settings. RESULTS: The comparison of the adaptive framework, which trains a single model using the data from all the settings, shows that it can offer consistently improved performance for each acquisition condition. The comparison of the proposed scheme with networks that are trained independently for each acquisition setting shows that it requires less training data per acquisition setting to offer good performance. CONCLUSION: The Ada-MoDL framework enables the use of a single model-based unrolled network for multiple acquisition settings. In addition to eliminating the need to train and store multiple networks for different acquisition settings, this approach reduces the training data needed for each acquisition setting.

A simple purification procedure of buffalo lung cathepsin H, its properties and influence of buffer constituents on the enzyme activity.

BACKGROUND: Cathepsin H (E.C.3.4.22.16) belongs to a family of lysosomal cysteine protease which regulates diverse normal biological processes mainly in intracellular proteolysis. METHODS: Purification of cathepsin H from an unstudied system i.e. buffalo lung has been achieved by a simple process developed after incorporating appropriate alteration in the available methods for isolation of the enzyme from other sources. The use of DEAE-Cellulose and SP-Sephadex C-50 helped in better and simultaneous separation of cathepsin B and H up to homogeneity. RESULTS: The SDS-PAGE result showed buffalo cathepsin H to be a single-chain molecule having MW, NH2- and COOH- terminal residues of 25.4 kDa, Lys and Val respectively. The enzyme was a glycoprotein with pI of 6.2; it hydrolyzed Leu-NA (Vmax/Km = 301.6) as the most efficient substrate followed by Arg-NA, Arg-Arg-NA and BANA. Buffalo enzyme showed maximum activity at 36 °C, pH 6.75 and at a buffer concentration of 2 × 10-3 M. CONCLUSION: Catheptic activity was found to be quite stable at least for 20-30 min between pH 4.5-7.0, buffer concentration of 1 × 10-2 to 4 × 10-2 M and the temperature resistance up to 36 °C. The effects of various substances present in the buffers routinely used for the assay of catheptic activity revealed that the activity of buffalo lung cathepsin H depends not only qualitatively but also quantitatively on the constituents of assay buffer. GENERAL SIGNIFICANCE: This study seems to provide valuable information regarding the biochemistry of cathepsin H in general as well as influence of buffer constituents on enzyme activity and physiological role in particular.

Muscle Infiltrative Adult Multisystem Langerhans Cell Histiocytosis Detected on Fluorodeoxyglucose Positron Emission Tomography/ Computed Tomography - A Rare Case.

Langerhans cell histiocytosis (LCH) is a disease of unknown pathogenesis characterized by the accumulation of Langerhans cells which show immunopositivity for S-100 and CD1a. LCH with skeletal muscle involvement has been rarely described in literature. 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) is an important tool in identifying the sites of involvement in LCH. We present a rare case of muscle invasive LCH where 18F-FDG PET/CT showed involvement of multiple other sites such as the liver, bones, bone marrow, and possibly the thyroid gland in our case. Further, the current case also shows that liver involvement by LCH (possibly fibrotic phase) can be negative on PET but show lesions on CT.

Diurnal Variation of Proton Density Fat Fraction in the Liver Using Quantitative Chemical Shift Encoded MRI.

BACKGROUND: Whole-organ, noninvasive techniques for the detection and quantification of nonalcoholic fatty liver disease features have clinical and research applications. However, the effect of time of day, hydration status, and meals are unknown factors with potential to impact bias, precision, reproducibility, and repeatability of chemical shift-encoded MRI (CSE-MRI) to quantify liver proton density fat fraction (PDFF). PURPOSE: To assess the effect of diurnal variation on PDFF using CSE-MRI, including the effect of time of day, the effect of meals and hydration status, as well as the day to day variability. STUDY TYPE: Prospective. SUBJECTS: Eleven healthy subjects and nine patients with observed hepatic steatosis. FIELD STRENGTH/SEQUENCES: A commercial quantitative confounder-corrected CSE-MRI sequence (IDEAL IQ) and an MR spectroscopy (MRS) sequence (multiecho STEAM) were acquired at 1.5T. ASSESSMENT: MRI-PDFF and MRS-PDFF estimates were compared across six visits (before and after a controlled breakfast, before and after an uncontrolled lunch, at approximately 4 pm, and then before breakfast on the following day) with three repeated measures for a total of 360 MRI-PDFF and MRS-PDFF measurements. STATISTICAL TESTS: Linear regression, Bland-Altman analysis, and mixed effect models were used to determine the bias, precision, and repeatability of PDFF measurements. RESULTS: No statistically significant linear trend was observed across visits for either MRI-PDFF or MRS-PDFF (P = 0.31 and 0.37, respectively). The repeatability was measured to be 0.86% for MRI-PDFF and 1.1% for MRS-PDFF over all six visits. For MRI-PDFF, the variability between all six visits (0.94%) was only slightly higher than within each visit (0.66%), with P < 0.001. For MRS-PDFF, the variability between all six visits was 1.29%, compared with 0.87% within each visit (P < 0.001). DATA CONCLUSION: Our results may indicate that it is not necessary to control for the time of day or the fasting/fed state of the patient when measuring PDFF using CSE-MRI. LEVEL OF EVIDENCE: 2 Technical Efficacy: Stage 2 J. Magn. Reson. Imaging 2020;51:407-414.

Pharmacokinetics of Ferumoxytol in the Abdomen and Pelvis: A Dosing Study with 1.5- and 3.0-T MRI Relaxometry.

Background The off-label use of ferumoxytol (FE), an intravenous iron preparation for iron deficiency anemia, as a contrast agent for MRI is increasing; therefore, it is critical to understand its pharmacokinetics. Purpose To evaluate the pharmacokinetics of FE in the abdomen and pelvis, as assessed with quantitative 1.5- and 3.0-T MRI relaxometry. Materials and Methods R2*, an MRI technique used to estimate tissue iron content in the abdomen and pelvis, was performed at 1.5 and 3.0 T in 12 healthy volunteers between April 2015 and January 2016. Volunteers were randomly assigned to receive an FE dose of 2 mg per kilogram of body weight (FE2mg) or 4 mg/kg (FE4mg). MRI was repeated at 1.5 and 3.0 T for each volunteer at five time points: days 1, 2, 4, 7, and 30. A radiologist experienced in MRI relaxometry measured R2* in organs of the mononuclear phagocyte system (MPS) (ie, liver, spleen, and bone marrow), non-MPS anatomy (kidney, pancreas, and muscle), inguinal lymph nodes (LNs), and blood pool. A paired Student t test was used to compare changes in tissue R2*. Results Volunteers (six female; mean age, 44.3 years ± 12.2 [standard deviation]) received either FE2 mg (n = 5) or FE4 mg (n = 6). Overall R2* trend analysis was temporally significant (P < .001). Time to peak R2* in the MPS occurred on day 1 for FE2mg and between days 1 and 4 for FE4mg (P < .001 to P < .002). Time to peak R2* in non-MPS anatomy, LNs, and blood pool occurred on day 1 for both doses (P < .001 to P < .09). Except for the spleen (at 1.5 T) and liver, MPS R2* remained elevated through day 30 for both doses (P = .02 to P = .03). Except for the kidney and pancreas, non-MPS, LN, and blood pool R2* returned to baseline levels between days 2 and 4 at FE2mg (P = .06 to P = .49) and between days 4 and 7 at FE4mg (P = .06 to P = .63). There was no difference in R2* change between non-MPS and LN R2* at any time (range, 1-71 sec-1 vs 0-50 sec-1; P = .06 to P = .97). Conclusion The pharmacokinetics of ferumoxytol in lymph nodes are distinct from those in mononuclear phagocyte system (MPS) organs, parallel non-MPS anatomy, and the blood pool. © RSNA, 2019 Online supplemental material is available for this article.

Role of apoplastic calcium during germination and initial stages of seedling establishment in Vigna radiata seeds.

Calcium (Ca2+) is implicated in the initial phase of seed germination and seedling establishment. It is stored complexed with phytic acid during seed development and released by phytase action during germination. We observed phytase activity 18 h post-imbibition (PI) in Vigna seeds, while radicle protrusion occurred approximately 12 h PI. Cotyledon protein extracts prepared 4, 8, 16 and 24 h PI, subjected to Ca2+ immobilized metal affinity chromatography (Ca2+ IMAC), revealed the presence of Ca2+ binding proteins (CaBPs), while Ca2+-dependent amylase activity peaked 18 h PI, implying Ca2+ presence before its release from Ca-phytate, indicating an alternative source of Ca2+. Vigna cotyledon cell-wall preparations 4 h and 24 h PI, titrated against alkali, revealed high cation-binding capacity, and seeds 4 h PI demonstrated high rates of H+ extrusion. Ca2+-binding capacity as well as cell-wall bound Ca2+, measured in cotyledon cell-wall preparations from unimbibed seeds as well as seeds 24 h PI, using a novel competitive chelation technique, showed a marked decline in Ca2+ binding capacity, as well as cell-wall bound Ca2+. Imbibition in the presence of chelators, Ca2+-channel blockers, and H+-pump inhibitors, interfered with germination and radical extension. Further, EDTA-treated cotyledon protein extracts separated on Ca2+IMAC showed a larger CaBP peak than control cotyledon extracts. Pooled fractions clearly showed Ca2+-induced extrinsic fluorescence with anilino -napthalene sulfonate. The results strongly implicate the apoplast may be a major source of Ca2+ in the initial phase of germination and seedling establishment in Vigna seeds.

Relaxivity of Ferumoxytol at 1.5 T and 3.0 T.

OBJECTIVES: The aim of this study was to determine the relaxation properties of ferumoxytol, an off-label alternative to gadolinium-based contrast agents, under physiological conditions at 1.5 T and 3.0 T. MATERIALS AND METHODS: Ferumoxytol was diluted in gradually increasing concentrations (0.26-4.2 mM) in saline, human plasma, and human whole blood. Magnetic resonance relaxometry was performed at 37°C at 1.5 T and 3.0 T. Longitudinal and transverse relaxation rate constants (R1, R2, R2*) were measured as a function of ferumoxytol concentration, and relaxivities (r1, r2, r2*) were calculated. RESULTS: A linear dependence of R1, R2, and R2* on ferumoxytol concentration was found in saline and plasma with lower R1 values at 3.0 T and similar R2 and R2* values at 1.5 T and 3.0 T (1.5 T: r1saline = 19.9 ± 2.3 smM; r1plasma = 19.0 ± 1.7 smM; r2saline = 60.8 ± 3.8 smM; r2plasma = 64.9 ± 1.8 smM; r2*saline = 60.4 ± 4.7 smM; r2*plasma = 64.4 ± 2.5 smM; 3.0 T: r1saline = 10.0 ± 0.3 smM; r1plasma = 9.5 ± 0.2 smM; r2saline = 62.3 ± 3.7 smM; r2plasma = 65.2 ± 1.8 smM; r2*saline = 57.0 ± 4.7 smM; r2*plasma = 55.7 ± 4.4 smM). The dependence of relaxation rates on concentration in blood was nonlinear. Formulas from second-order polynomial fittings of the relaxation rates were calculated to characterize the relationship between R1blood and R2 blood with ferumoxytol. CONCLUSIONS: Ferumoxytol demonstrates strong longitudinal and transverse relaxivities. Awareness of the nonlinear relaxation behavior of ferumoxytol in blood is important for ferumoxytol-enhanced magnetic resonance imaging applications and for protocol optimization.

Quantitative magnetic resonance imaging phantoms: A review and the need for a system phantom.

The MRI community is using quantitative mapping techniques to complement qualitative imaging. For quantitative imaging to reach its full potential, it is necessary to analyze measurements across systems and longitudinally. Clinical use of quantitative imaging can be facilitated through adoption and use of a standard system phantom, a calibration/standard reference object, to assess the performance of an MRI machine. The International Society of Magnetic Resonance in Medicine AdHoc Committee on Standards for Quantitative Magnetic Resonance was established in February 2007 to facilitate the expansion of MRI as a mainstream modality for multi-institutional measurements, including, among other things, multicenter trials. The goal of the Standards for Quantitative Magnetic Resonance committee was to provide a framework to ensure that quantitative measures derived from MR data are comparable over time, between subjects, between sites, and between vendors. This paper, written by members of the Standards for Quantitative Magnetic Resonance committee, reviews standardization attempts and then details the need, requirements, and implementation plan for a standard system phantom for quantitative MRI. In addition, application-specific phantoms and implementation of quantitative MRI are reviewed. Magn Reson Med 79:48-61, 2018. © 2017 International Society for Magnetic Resonance in Medicine.

Thrombus-mimicking artifacts in two-point Dixon MRI: Prevalence, appearance, and severity.

PURPOSE: To evaluate the incidence and severity of potentially thrombus mimicking, flow-induced misallocation artifacts in a clinical setting. Two-point "Dixon" fat-water separation methods, with bipolar readout gradients, may suffer from flow-induced fat-water misallocation artifacts. If these artifacts occur within blood vessels, they may mimic thrombus. MATERIALS AND METHODS: Two-point Dixon coronal and axial images acquired in 102 consecutive patients were retrospectively evaluated for the presence of flow-induced artifacts in arteries and veins. Artifacts were graded on a 3-point scale (none, mild, severe) by two independent readers. Interreader agreement was evaluated with kappa statistics. RESULTS: Reader 1 reported 63 artifacts in 46 (45%) of the cases (severe in 19 cases, 18.6%). Reader 2 reported 51 artifacts in 43 (42.2%) of the cases (severe in 18 cases, 17.6%). Misallocation of fat and water was apparent in all datasets with severe artifacts, whereas variable signal intensity changes in water and fat images were observed in mild artifacts. Interreader agreement was good for artifacts appearing in coronal images (κ = 0.7) and fair for artifact appearance in axial images (κ = 0.24). CONCLUSION: Our study shows a high incidence of flow-induced mild and severe artifacts in a two-point Dixon method with bipolar readout gradients. This artifact should not be misinterpreted as intravascular thrombus. LEVEL OF EVIDENCE: 3 J. Magn. Reson. Imaging 2017;45:229-236.

The effects of concomitant gradients on chemical shift encoded MRI.

PURPOSE: The purpose of this work was to characterize the effects of concomitant gradients (CGs) on chemical shift encoded (CSE)-based estimation of B0 field map, proton density fat fraction (PDFF), and R2*. THEORY: A theoretical framework was used to determine the effects of CG-induced phase errors on CSE-MRI data. METHODS: Simulations, phantom experiments, and in vivo experiments were conducted at 3 Tesla to assess the effects of CGs on quantitative CSE-MRI techniques. Correction of phase errors attributable to CGs was also investigated to determine whether these effects could be removed. RESULTS: Phase errors attributed to CGs introduce errors in the estimation of B0 field map, PDFF, and R2*. Phantom and in vivo experiments demonstrated that CGs can introduce estimation errors greater than 30 Hz in the B0 field map, 10% in PDFF, and 16 s-1 in R2*, 16 cm off isocenter. However, CG phase correction before parameter estimation was able to reduce estimation errors to less than 10 Hz in the B0 field map, 1% in PDFF, and 2 s-1 in R2*. CONCLUSION: CG effects can impact CSE-MRI, leading to inaccurate estimation of B0 field map, PDFF, and R2*. However, correction for phase errors caused by CGs improve the accuracy of quantitative parameters estimated from CSE-MRI acquisitions. Magn Reson Med 78:730-738, 2017. © 2016 International Society for Magnetic Resonance in Medicine.

MRI-based quantitative susceptibility mapping (QSM) and R2* mapping of liver iron overload: Comparison with SQUID-based biomagnetic liver susceptometry.

PURPOSE: We aimed to determine the agreement between quantitative susceptibility mapping (QSM)-based biomagnetic liver susceptometry (BLS) and confounder-corrected R2* mapping with superconducting quantum interference device (SQUID)-based biomagnetic liver susceptometry in patients with liver iron overload. METHODS: Data were acquired from two healthy controls and 22 patients undergoing MRI and SQUID-BLS as part of routine monitoring for iron overload. Magnetic resonance imaging was performed on a 3T system using a three-dimensional multi-echo gradient-echo acquisition. Both magnetic susceptibility and R2* of the liver were estimated from this acquisition. Linear regression was used to compare estimates of QSM-BLS and R2* to SQUID-BLS. RESULTS: Both QSM-BLS and confounder-corrected R2* were sensitive to the presence of iron in the liver. Linear regression between QSM-BLS and SQUID-BLS demonstrated the following relationship: QSM-BLS = (-0.22 ± 0.11) + (0.49 ± 0.05) · SQUID-BLS with r2 = 0.88. The coefficient of determination between liver R2* and SQUID-BLS was also r2 = 0.88. CONCLUSION: We determined a strong correlation between both QSM-BLS and confounder-corrected R2* to SQUID-BLS. This study demonstrates the feasibility of QSM-BLS and confounder-corrected R2* for assessing liver iron overload, particularly when SQUID systems are not accessible. Magn Reson Med 78:264-270, 2017. © 2016 International Society for Magnetic Resonance in Medicine.

Crossover comparison of ferumoxytol and gadobenate dimeglumine for abdominal MR-angiography at 3.0 tesla: Effects of contrast bolus length and flip angle.

PURPOSE: Ferumoxytol (FE) has gained interest as an alternative to gadolinium-based contrast agents (GBCAs). The purpose of this study was to evaluate and optimize ferumoxytol dose and T1 weighting, in comparison to a conventional GBCA. MATERIALS AND METHODS: Twelve healthy volunteers (six women / six men, mean age 44.3 years) were recruited for this study. Scanning was performed on a clinical 3 Tesla (T) MRI system. Gadobenate dimeglumine (GD)-enhanced MRA was performed followed by FE-enhanced MRA 1 month later. Volunteers were randomly assigned to a diluted (n = 6) or undiluted (n = 6) dose of GD (0.1 mmol/kg), and to FE doses of 4 mg/kg (n = 6) or 2 mg/kg (n = 6). First pass and steady-state MRA were performed for GD- and FE-enhanced MRA. Flip-angle optimization was performed after FE administration. Quantitative analysis included relative contrast-to-noise ratio (relCNR) measurements for all acquisitions. First pass GD- and FE-enhanced MRA images were evaluated qualitatively. RESULTS: RelCNR was significantly higher with undiluted GD (31.8, 95% confidence interval [CI], 27.7-35.9) compared with diluted GD (16.2; 95% CI, 12.2-20.3; P = 0.001) and both 4 mg/kg FE (12.5; 95% CI, 8.5-16.4; P < 0.001) and 2 mg/kg FE (9.1; 95% CI, 5.1-13.2; P < 0.001) during first pass. Relative CNR did not decrease with FE 5 min postinjection compared with GD. Flip-angle analysis revealed relative CNR-peaks at 30° for FE 4 mg/kg and at 20° for FE 2 mg/kg. Diluted GD (P = 0.013) and FE 4 mg/kg (P = 0.01) revealed significantly higher image quality scores compared with undiluted GD during first pass. CONCLUSION: This study shows an equivalent image quality of FE and GD for first pass MRA even though GD showed significantly higher relative CNR. LEVEL OF EVIDENCE: 1 Technical Efficacy: Stage 2 J. MAGN. RESON. IMAGING 2017;45:1617-1626.

Multisite, multivendor validation of the accuracy and reproducibility of proton-density fat-fraction quantification at 1.5T and 3T using a fat-water phantom.

PURPOSE: To evaluate the accuracy and reproducibility of quantitative chemical shift-encoded (CSE) MRI to quantify proton-density fat-fraction (PDFF) in a fat-water phantom across sites, vendors, field strengths, and protocols. METHODS: Six sites (Philips, Siemens, and GE Healthcare) participated in this study. A phantom containing multiple vials with various oil/water suspensions (PDFF:0%-100%) was built, shipped to each site, and scanned at 1.5T and 3T using two CSE protocols per field strength. Confounder-corrected PDFF maps were reconstructed using a common algorithm. To assess accuracy, PDFF bias and linear regression with the known PDFF were calculated. To assess reproducibility, measurements were compared across sites, vendors, field strengths, and protocols using analysis of covariance (ANCOVA), Bland-Altman analysis, and the intraclass correlation coefficient (ICC). RESULTS: PDFF measurements revealed an overall absolute bias (across sites, field strengths, and protocols) of 0.22% (95% confidence interval, 0.07%-0.38%) and R2 > 0.995 relative to the known PDFF at each site, field strength, and protocol, with a slope between 0.96 and 1.02 and an intercept between -0.56% and 1.13%. ANCOVA did not reveal effects of field strength (P = 0.36) or protocol (P = 0.19). There was a significant effect of vendor (F = 25.13, P = 1.07 × 10-10 ) with a bias of -0.37% (Philips) and -1.22% (Siemens) relative to GE Healthcare. The overall ICC was 0.999. CONCLUSION: CSE-based fat quantification is accurate and reproducible across sites, vendors, field strengths, and protocols. Magn Reson Med 77:1516-1524, 2017. © 2016 International Society for Magnetic Resonance in Medicine.

Reactive oxygen species mediate axis-cotyledon signaling to induce reserve mobilization during germination and seedling establishment in Vigna radiata.

Seeds represent an excellent opportunity to investigate the role of reactive oxygen species (ROS) in control of metabolism during germination and seedling establishment. Cotyledons, the storage organs in Vigna, do not display growth/cell division while the embryonic axis shows rapid growth and intense metabolic activity. The present study investigates the possibility of ROS generated during respiration in the axis serving as messengers guiding storage reserve mobilization from cotyledons at the pre-greening stage. Seeds were germinated in the presence of hydroxyurea to halt cell division in the S-phase and separately in Edaravone, a potent free radical scavenger. Both treatments caused a decrease in germination percentage, seedling growth and protein mobilization. In the growing axis, both treatments resulted in a decrease in hydrogen peroxide (H2O2), total ROS, MDA and protein carbonyls. The picture in cotyledons was quite different, owing to the physiological dissimilarities between the tissues. The status of redox as evident by GSH/GSSG ratios tended toward oxidizing in axis in comparison to the highly reducing environment found in cotyledons. This is construed as a tendency to maintain redox buffering on the oxidizing side in the axis, to facilitate the passage of ROS message. These results strongly indicate that suppression of cell division or scavenging of ROS adversely affects protein reserve mobilization. It is proposed that apart from H2O2 being a transportable signal, the final message perceived in cotyledons also comprises lipid peroxidation, protein carbonylation and alteration of redox status of the glutathione pool.

Quantitative magnetic resonance imaging of hepatic steatosis: Validation in ex vivo human livers.

UNLABELLED: Emerging magnetic resonance imaging (MRI) biomarkers of hepatic steatosis have demonstrated tremendous promise for accurate quantification of hepatic triglyceride concentration. These methods quantify the proton density fat-fraction (PDFF), which reflects the concentration of triglycerides in tissue. Previous in vivo studies have compared MRI-PDFF with histologic steatosis grading for assessment of hepatic steatosis. However, the correlation of MRI-PDFF with the underlying hepatic triglyceride content remained unknown. The aim of this ex vivo study was to validate the accuracy of MRI-PDFF as an imaging biomarker of hepatic steatosis. Using ex vivo human livers, we compared MRI-PDFF with magnetic resonance spectroscopy-PDFF (MRS-PDFF), biochemical triglyceride extraction, and histology as three independent reference standards. A secondary aim was to compare the precision of MRI-PDFF relative to biopsy for the quantification of hepatic steatosis. MRI-PDFF was prospectively performed at 1.5 Tesla in 13 explanted human livers. We performed colocalized paired evaluation of liver fat content in all nine Couinaud segments using single-voxel MRS-PDFF (n=117) and tissue wedges for biochemical triglyceride extraction (n=117), and five core biopsies performed in each segment for histologic grading (n=585). Accuracy of MRI-PDFF was assessed through linear regression with MRS-PDFF, triglyceride extraction, and histology. Intraobserver agreement, interobserver agreement, and repeatability of MRI-PDFF and histologic grading were assessed through Bland-Altman analyses. MRI-PDFF showed an excellent correlation with MRS-PDFF (r=0.984, confidence interval 0.978-0.989) and strong correlation with histology (r=0.850, confidence interval 0.791-0.894) and triglyceride extraction (r=0.871, confidence interval 0.818-0.909). Intraobserver agreement, interobserver agreement, and repeatability showed a significantly smaller variance for MRI-PDFF than for histologic steatosis grading (all P<0.001). CONCLUSION: MRI-PDFF is an accurate, precise, and reader-independent noninvasive imaging biomarker of liver triglyceride content, capable of steatosis quantification over the entire liver.

Quantitative susceptibility mapping in the abdomen as an imaging biomarker of hepatic iron overload.

PURPOSE: The purpose of this work was to develop and demonstrate feasibility and initial clinical validation of quantitative susceptibility mapping (QSM) in the abdomen as an imaging biomarker of hepatic iron overload. THEORY AND METHODS: In general, QSM is faced with the challenges of background field removal and dipole inversion. Respiratory motion, the presence of fat, and severe iron overload further complicate QSM in the abdomen. We propose a technique for QSM in the abdomen that addresses these challenges. Data were acquired from 10 subjects without hepatic iron overload and 33 subjects with known or suspected iron overload. The proposed technique was used to estimate the susceptibility map in the abdomen, from which hepatic iron overload was measured. As a reference, spin-echo data were acquired for R2-based LIC estimation. Liver R2* was measured for correlation with liver susceptibility estimates. RESULTS: Correlation between susceptibility and R2-based LIC estimation was R(2) = 0.76 at 1.5 Tesla (T) and R(2) = 0.83 at 3T. Furthermore, high correlation between liver susceptibility and liver R2* (R(2) = 0.94 at 1.5T; R(2) = 0.93 at 3T) was observed. CONCLUSION: We have developed and demonstrated initial validation of QSM in the abdomen as an imaging biomarker of hepatic iron overload.

Improving chemical shift encoded water-fat separation using object-based information of the magnetic field inhomogeneity.

PURPOSE: The purpose of this work was to improve the robustness of existing chemical shift encoded water-fat separation methods by incorporating object-based information of the B0 field inhomogeneity. THEORY: The primary challenge in water-fat separation is the estimation of phase shifts that arise from B0 field inhomogeneity, which is composed of the background field and susceptibility-induced field. The susceptibility-induced field can be estimated if the susceptibility distribution is known or can be approximated. In this work, the susceptibility distribution is approximated from the source images using the known susceptibility values of water, fat, and air. The field estimate is then demodulated from the source images before water-fat separation. METHODS: Chemical shift encoded source images were acquired in anatomical regions that are prone to water-fat swaps. The images were processed using algorithms from the ISMRM Fat-Water Toolbox, with and without the object-based field map information. The estimates were compared to examine the benefit of using the object-based field map information. RESULTS: Multiple cases are shown in which water-fat swaps were avoided by using the object-based information of the B0 field map. CONCLUSION: Object-based information of the B0 field may improve the robustness of existing chemical shift encoded water-fat separation methods.

On the confounding effect of temperature on chemical shift-encoded fat quantification.

PURPOSE: To characterize the confounding effect of temperature on chemical shift-encoded (CSE) fat quantification. METHODS: The proton resonance frequency of water, unlike triglycerides, depends on temperature. This leads to a temperature dependence of the spectral models of fat (relative to water) that are commonly used by CSE-MRI methods. Simulation analysis was performed for 1.5 Tesla CSE fat-water signals at various temperatures and echo time combinations. Oil-water phantoms were constructed and scanned at temperatures between 0 and 40°C using spectroscopy and CSE imaging at three echo time combinations. An explanted human liver, rejected for transplantation due to steatosis, was scanned using spectroscopy and CSE imaging. Fat-water reconstructions were performed using four different techniques: magnitude and complex fitting, with standard or temperature-corrected signal modeling. RESULTS: In all experiments, magnitude fitting with standard signal modeling resulted in large fat quantification errors. Errors were largest for echo time combinations near TEinit ≈ 1.3 ms, ΔTE ≈ 2.2 ms. Errors in fat quantification caused by temperature-related frequency shifts were smaller with complex fitting, and were avoided using a temperature-corrected signal model. CONCLUSION: Temperature is a confounding factor for fat quantification. If not accounted for, it can result in large errors in fat quantifications in phantom and ex vivo acquisitions.

Clinical image quality assessment of accelerated magnetic resonance neuroimaging using compressed sensing.

PURPOSE: The aim of this study was to determine to what degree current compressed sensing methods are capable of accelerating clinical magnetic resonance neuroimaging sequences. METHODS: Two 2-dimensional clinical sequences were chosen for this study because of their long scan times. A pilot study was used to establish the sampling scheme and regularization parameter needed in compressed sensing reconstruction. These findings were used in a subsequent blinded study in which images reconstructed using compressed sensing were evaluated by 2 board-certified neuroradiologists. Image quality was evaluated at up to 10 anatomical features. RESULTS: The findings indicate that compressed sensing may provide 2-fold acceleration of certain clinical magnetic resonance neuroimaging sequences. A global ringing artifact and image blurring were identified as the 2 primary artifacts that would hinder the ability to confidently discern abnormality. CONCLUSION: Compressed sensing is able to moderately accelerate certain neuroimaging sequences without severe loss of clinically relevant information. For those sequences with coarser spatial resolution and/or at a higher acceleration factor, artifacts degrade the quality of the reconstructed image to a point where they are of little to no clinical value.

Accelerated T2*-compensated fat fraction quantification using a joint parallel imaging and compressed sensing framework.

PURPOSE: To develop a T2*-compensated parallel imaging and compressed sensing framework for water-fat separation, and to demonstrate accelerated quantitative imaging of proton density fat fraction. MATERIALS AND METHODS: The proposed method extends a previously developed framework for water-fat separation by additionally compensating for T2* decay. A two-stage estimation was formulated that first determines an approximation of the B0 field map and then jointly estimates and refines the R2* (=1/T2*) and B0 field maps, respectively. The method was tested using a set of water-fat phantoms as well as liver datasets that were acquired from seven asymptomatic adult volunteers. The fat fraction estimates were compared to those from a commonly used nonaccelerated water-fat imaging method and also to a sequential parallel imaging and water-fat imaging method. RESULTS: The proposed method properly compensated for T2* decay to yield accurate fat fraction estimates in the water-fat phantoms. Further, linear regression analysis from the liver datasets showed that the proposed method accurately estimated fat fraction at acceleration factors that were higher than those achievable by the sequential parallel imaging and water-fat imaging method. Accurate fat fraction estimates were demonstrated at acceleration factors up to 4×, although some image artifacts were observed. CONCLUSION: The proposed T2*-compensated parallel imaging and compressed sensing framework demonstrates the potential to further accelerate water-fat imaging while maintaining accurate estimates of proton density fat fraction.